CXCL12 and hepatocellular carcinoma: Moreover, CXCL12 and CXCR4 polymorphisms appear to contribute to increased risk of hepatocellular carcinoma (HCC) and may be potential markers for HCC (Chang et al., 2009; Qin et al., 2018).